CHARM THERAPEUTICS INC.
Profile
Company Names
CHARM THERAPEUTICS INC.
Addresses
7 PANCRAS SQUARE, LONDON, X0 N1C 4AG
7 PANCRAS SQ, LONDON, X0 N1C 4AG
THE STANLEY BUILDING, 7 PANCRAS SQUARE, LONDON, X0 N1C 4AG
33 FOLEY STREET, LONDON, X0 W1W 7TL
Phone Numbers
447582703655
Entity Type:
CORPORATION
Industry:
OTHER, OTHER HEALTH CARE
Year Incorporated:
2021
State Incorporated:
DELAWARE
Total Amount Raised:
$86,980,697.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-08-19
$17,290,119.00
$80,095,754.00
$62,805,635.00
Equity
3
2023-04-06
$20,045,588.00
$20,045,588.00
$0.00
Equity
2
2022-04-18
$36,999,990.00
$36,999,990.00
$0.00
Equity
1
2021-10-14
$12,645,000.00
$13,500,000.00
$855,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
GARY
GLICK
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RISHI
GUPTA
DIRECTOR
GELESIS INC
| SIENTRA, INC.
| AVITIDE, INC.
| SYMBIOMIX THERAPEUTICS, LLC
| DIMENSION THERAPEUTICS, INC.
| MEVES PHARMACEUTICALS, INC.
| ATTENUA, INC.
| TURNSTONE BIOLOGICS CORP.
| GOLDEN TEAK CAPITAL L.P.
| NEUROPACE INC
| VERONA PHARMA PLC
| CHARM THERAPEUTICS INC.
| DELFI DIAGNOSTICS, INC.
| AER THERAPEUTICS, INC.
| HELICORE BIOVENTURES I, INC.
| ENLIVEN THERAPEUTICS, INC.
| WILSHIRE SELECTIVE OPPORTUNITIES PROGRAM SPC - WILSOP SEGREGATED PORTFOLIO 5
MUZAMMIL
MANSURI
DIRECTOR
BRIGGS
MORRISON
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

